SDGR

SEC source: 0001490978-25-000036 · wk-form4_1744749073.xml · nonDerivative · entry 3

Akinsanya Karen · CIK 0001797672 · President of R&D, Therapeutics

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,970

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (4) of this form 4.

F2 · balance_after: Includes 15,625 unvested RSUs.

SEC source: 0001490978-25-000036 · wk-form4_1744749073.xml · nonDerivative · entry 2

Akinsanya Karen · CIK 0001797672 · President of R&D, Therapeutics

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,348

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2024.

F2 · balance_after: Includes 15,625 unvested RSUs.

SEC source: 0001490978-25-000036 · wk-form4_1744749073.xml · nonDerivative · entry 1

Akinsanya Karen · CIK 0001797672 · President of R&D, Therapeutics

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,003

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2024.

F2 · balance_after: Includes 15,625 unvested RSUs.

SEC source: 0001490978-25-000028 · wk-form4_1741638943.xml · derivative · entry 2

van Kralingen Bridget A · CIK 0001538977 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,050

Underlying: Common Stock · 17,050 shares

Expires 2035-03-07

F3 · derivative.exercise_date: The option was granted on March 07, 2025. The award shall vest as to 33.3333% of the shares underlying each award on each of the first, second and third anniversaries of the date of grant of the awards, subject to continued service.

SEC source: 0001490978-25-000028 · wk-form4_1741638943.xml · nonDerivative · entry 1

van Kralingen Bridget A · CIK 0001538977 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 07, 2025 and shall vest as to 33.3333% of the shares underlying each award on each of the first, second and third anniversaries of the date of grant of the awards, subject to continued service. The settlement of such RSUs will be deferred until the earlier of (i) the 30th day following the reporting person's separation from service from the Issuer or (ii) certain change in control events.

F2 · balance_after: Includes 10,000 unvested RSUs.

SEC source: 0001490978-25-000024 · wk-form4_1741382038.xml · nonDerivative · entry 1

Herman Jenny · CIK 0001797785 · SVP & Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,349

F1 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on March 11, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 19,285 unvested RSUs.

SEC source: 0001490978-25-000017 · wk-form4_1741127207.xml · derivative · entry 2

Lorton Kenneth Patrick · CIK 0001797730 · EVP, CTO & COO, Software

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-03-03

F3 · derivative.exercise_date: The option was granted on March 3, 2025. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.

SEC source: 0001490978-25-000017 · wk-form4_1741127207.xml · nonDerivative · entry 1

Lorton Kenneth Patrick · CIK 0001797730 · EVP, CTO & COO, Software

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,576

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 3, 2025 and will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service with the company.

F2 · balance_after: Includes 16,585 unvested RSUs.

SEC source: 0001490978-25-000022 · wk-form4_1741127385.xml · derivative · entry 4

Porges Geoffrey Craig · CIK 0001938826 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-03-03

F5 · derivative.exercise_date: The option was granted on March 3, 2025. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.

SEC source: 0001490978-25-000022 · wk-form4_1741127385.xml · nonDerivative · entry 3

Porges Geoffrey Craig · CIK 0001938826 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,544

F4 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on August 16, 2022 and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of the PRSUs on March 3, 2025. The sale does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 12,500 unvested RSUs.

SEC source: 0001490978-25-000022 · wk-form4_1741127385.xml · nonDerivative · entry 2

Porges Geoffrey Craig · CIK 0001938826 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,035

F3 · kind: Represents the portion of the performance-based restricted stock units ("PRSUs") that were awarded to the reporting person on August 18, 2022 in connection with the commencement of his employment that vested on March 3, 2025 following certification by the compensation committee of the issuer's board of directors of the level of achievement of certain performance metrics for the PRSUs.

F2 · balance_after: Includes 12,500 unvested RSUs.

SEC source: 0001490978-25-000022 · wk-form4_1741127385.xml · nonDerivative · entry 1

Porges Geoffrey Craig · CIK 0001938826 · EVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,185

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 3, 2025 and will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service with the company.

F2 · balance_after: Includes 12,500 unvested RSUs.

SEC source: 0001490978-25-000021 · wk-form4_1741127348.xml · derivative · entry 2

Akinsanya Karen · CIK 0001797672 · President of R&D, Therapeutics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2035-03-03

F3 · derivative.exercise_date: The option was granted on March 3, 2025. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.

SEC source: 0001490978-25-000021 · wk-form4_1741127348.xml · nonDerivative · entry 1

Akinsanya Karen · CIK 0001797672 · President of R&D, Therapeutics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,625

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 3, 2025 and will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service with the company.

F2 · balance_after: Includes 15,625 unvested RSUs.

SEC source: 0001490978-25-000020 · wk-form4_1741127315.xml · derivative · entry 3

Farid Ramy · CIK 0001797707 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2035-03-03

F4 · derivative.exercise_date: The option was granted on March 3, 2025. The exercise price per share is equal to 110% of the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.

SEC source: 0001490978-25-000020 · wk-form4_1741127315.xml · derivative · entry 2

Farid Ramy · CIK 0001797707 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2035-03-03

F3 · derivative.exercise_date: The option was granted on March 3, 2025. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.

SEC source: 0001490978-25-000020 · wk-form4_1741127315.xml · nonDerivative · entry 1

Farid Ramy · CIK 0001797707 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 221,932

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 3, 2025 and will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service with the company.

F2 · balance_after: Includes 37,500 unvested RSUs.

SEC source: 0001490978-25-000019 · wk-form4_1741127266.xml · derivative · entry 2

Dugan Margaret · CIK 0001909734 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-03-03

F3 · derivative.exercise_date: The option was granted on March 3, 2025. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.

SEC source: 0001490978-25-000019 · wk-form4_1741127266.xml · nonDerivative · entry 1

Dugan Margaret · CIK 0001909734 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,969

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 3, 2025 and will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service with the company.

F2 · balance_after: Includes 23,750 unvested RSUs.

SEC source: 0001490978-25-000018 · wk-form4_1741127236.xml · derivative · entry 2

Herman Jenny · CIK 0001797785 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,400

Underlying: Common Stock · 8,400 shares

Expires 2035-03-03

F3 · derivative.exercise_date: The option was granted on March 3, 2025. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.

SEC source: 0001490978-25-000018 · wk-form4_1741127236.xml · nonDerivative · entry 1

Herman Jenny · CIK 0001797785 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,015

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 3, 2025 and will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service with the company.

F2 · balance_after: Includes 21,113 unvested RSUs.

SEC source: 0001490978-25-000016 · wk-form4_1741127182.xml · derivative · entry 2

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-03-03

F3 · derivative.exercise_date: The option was granted on March 3, 2025. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.

SEC source: 0001490978-25-000016 · wk-form4_1741127182.xml · nonDerivative · entry 1

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,635

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 3, 2025 and will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service with the company.

F2 · balance_after: Includes 16,295 unvested RSUs.

SEC source: 0001490978-25-000015 · wk-form4_1741127151.xml · derivative · entry 2

Abel Robert Lorne · CIK 0001798179 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-03-03

F3 · derivative.exercise_date: The option was granted on March 3, 2025. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.

SEC source: 0001490978-25-000015 · wk-form4_1741127151.xml · nonDerivative · entry 1

Abel Robert Lorne · CIK 0001798179 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,615

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 3, 2025 and will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service with the company.

F2 · balance_after: Includes 17,773 unvested RSUs.

SEC source: 0001490978-25-000007 · wk-form4_1739999362.xml · derivative · entry 3

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,902 shares

Expires 2028-11-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2024.

F3 · derivative.exercise_date: The option was granted on November 29, 2018 and is fully vested.

SEC source: 0001490978-25-000007 · wk-form4_1739999362.xml · nonDerivative · entry 2

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,135

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2024.

F2 · balance_after: Includes 3,795 unvested RSUs.

SEC source: 0001490978-25-000007 · wk-form4_1739999362.xml · nonDerivative · entry 1

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,037

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2024.

F2 · balance_after: Includes 3,795 unvested RSUs.

SEC source: 0001490978-25-000004 · wk-form4_1739394476.xml · nonDerivative · entry 1

Lorton Kenneth Patrick · CIK 0001797730 · EVP, CTO & COO, Software

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,076

F1 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on March 9, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 4,085 unvested RSUs.

SEC source: 0001490978-25-000003 · wk-form4_1739394448.xml · nonDerivative · entry 1

Herman Jenny · CIK 0001797785 · SVP & Controller

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,215

F1 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on March 11, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 11,313 unvested RSUs.

SEC source: 0001490978-25-000002 · wk-form4_1739394421.xml · nonDerivative · entry 1

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,135

F1 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on March 8, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 3,795 unvested RSUs.

SEC source: 0001490978-25-000005 · wk-form4_1739394536.xml · nonDerivative · entry 1

Abel Robert Lorne · CIK 0001798179 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,115

F1 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on June 13, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 5,273 unvested RSUs.

SEC source: 0001490978-24-000080 · wk-form4_1729113841.xml · nonDerivative · entry 1

Dugan Margaret · CIK 0001909734 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,469

F1 · kind: This sale was effected pursuant to a durable automatic sale instruction under Rule 10b5-1 adopted by the reporting person on November 13, 2023, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). The sale does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 11,250 unvested RSUs.

SEC source: 0001490978-24-000062 · wk-form4_1718914921.xml · derivative · entry 2

Chodakewitz Jeffrey · CIK 0001610876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,550

Underlying: Common Stock · 8,550 shares

Expires 2034-06-18

F3 · derivative.exercise_date: The option was granted on June 18, 2024. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001490978-24-000062 · wk-form4_1718914921.xml · nonDerivative · entry 1

Chodakewitz Jeffrey · CIK 0001610876 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,250

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 18, 2024 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 5,000 unvested RSUs.

SEC source: 0001490978-24-000061 · wk-form4_1718914892.xml · derivative · entry 2

Kapeller-Libermann Rosana · CIK 0001797835 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,550

Underlying: Common Stock · 8,550 shares

Expires 2034-06-18

F3 · derivative.exercise_date: The option was granted on June 18, 2024. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001490978-24-000061 · wk-form4_1718914892.xml · nonDerivative · entry 1

Kapeller-Libermann Rosana · CIK 0001797835 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,250

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 18, 2024 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 5,000 unvested RSUs.

SEC source: 0001490978-24-000060 · wk-form4_1718914852.xml · derivative · entry 2

Lynton Michael · CIK 0001606115 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,550

Underlying: Common Stock · 8,550 shares

Expires 2034-06-18

F3 · derivative.exercise_date: The option was granted on June 18, 2024. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001490978-24-000060 · wk-form4_1718914852.xml · nonDerivative · entry 1

Lynton Michael · CIK 0001606115 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,250

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 18, 2024 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 5,000 unvested RSUs.

SEC source: 0001490978-24-000059 · wk-form4_1718914823.xml · derivative · entry 2

OBEROI ARUN · CIK 0001275887 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,550

Underlying: Common Stock · 8,550 shares

Expires 2034-06-18

F3 · derivative.exercise_date: The option was granted on June 18, 2024. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001490978-24-000059 · wk-form4_1718914823.xml · nonDerivative · entry 1

OBEROI ARUN · CIK 0001275887 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,250

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 18, 2024 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 5,000 unvested RSUs.

SEC source: 0001490978-24-000057 · wk-form4_1718914747.xml · derivative · entry 2

Sender Gary · CIK 0001659085 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,550

Underlying: Common Stock · 8,550 shares

Expires 2034-06-18

F3 · derivative.exercise_date: The option was granted on June 18, 2024. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001490978-24-000057 · wk-form4_1718914747.xml · nonDerivative · entry 1

Sender Gary · CIK 0001659085 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,250

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 18, 2024 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 5,000 unvested RSUs.

SEC source: 0001490978-24-000056 · wk-form4_1718914649.xml · derivative · entry 2

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,550

Underlying: Common Stock · 8,550 shares

Expires 2034-06-18

F3 · derivative.exercise_date: The option was granted on June 18, 2024. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001490978-24-000056 · wk-form4_1718914649.xml · nonDerivative · entry 1

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,250

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 18, 2024 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 5,000 unvested RSUs.

SEC source: 0001490978-24-000055 · wk-form4_1718914610.xml · derivative · entry 4

Friesner Richard · CIK 0001798426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,550

Underlying: Common Stock · 8,550 shares

Expires 2034-06-18

F4 · derivative.exercise_date: The option was granted on June 18, 2024. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001490978-24-000055 · wk-form4_1718914610.xml · nonDerivative · entry 1

Friesner Richard · CIK 0001798426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 515,700

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 18, 2024 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 5,000 unvested RSUs.

SEC source: 0001490978-24-000053 · wk-form4_1718914522.xml · derivative · entry 2

GINSBERG GARY L · CIK 0001236136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,550

Underlying: Common Stock · 8,550 shares

Expires 2034-06-18

F3 · derivative.exercise_date: The option was granted on June 18, 2024. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001490978-24-000053 · wk-form4_1718914522.xml · nonDerivative · entry 1

GINSBERG GARY L · CIK 0001236136 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,250

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 18, 2024 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

F2 · balance_after: Includes 5,000 unvested RSUs.

SEC source: 0001490978-24-000022 · wk-form4_1711138922.xml · derivative · entry 1

Lorton Kenneth Patrick · CIK 0001797730 · EVP, CTO & COO, Software

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-03-21

F1 · derivative.exercise_date: The option was granted on March 21, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.